Literature DB >> 9598849

Continuous non-seasonal epidemic of respiratory syncytial virus infection in the southeast United States.

D C Halstead1, S G Jenkins.   

Abstract

BACKGROUND: This study was done to define the seasonality of respiratory syncytial virus (RSV) epidemics in the southeastern United States.
METHODS: We tested 5,092 fresh nasal aspirates or washings, using the Kallestad Pathfinder enzyme immunoassay (EIA) or the Directigen RSV membrane EIA according to manufacturers' directions.
RESULTS: A total of 1,419 (27.9%) respiratory specimens, collected from pediatric patients between May 1993 and December 1996 at two large southeastern medical centers, were positive for RSV antigen by enzyme immunoassay. A persistent RSV epidemic was documented between July 1993 and December 1996. We defined an epidemic as 2 consecutive months in each of which > or = 10% of the specimens were positive and > or = 2 positive specimens detected. The highest percentages of positive specimens were detected in December of 1993, 1994, and 1996, to date, and November 1995.
CONCLUSION: On the basis of our findings, we recommend health care workers consider RSV in the differential diagnosis of acute respiratory illness throughout the year in pediatric patients from the southeast United States.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9598849     DOI: 10.1097/00007611-199805000-00004

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  9 in total

1.  Molecular epidemiology of subgroup C avian pneumoviruses isolated in the United States and comparison with subgroup a and B viruses.

Authors:  Hyun-Jin Shin; Kjerstin T Cameron; Janet A Jacobs; Elizabeth A Turpin; David A Halvorson; Sagar M Goyal; Kakambi V Nagaraja; Mahesh C Kumar; Dale C Lauer; Bruce S Seal; M Kariuki Njenga
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection.

Authors:  Melinda M Pettigrew; Janneane F Gent; Richard B Pyles; Aaron L Miller; Johanna Nokso-Koivisto; Tasnee Chonmaitree
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

3.  The role of human metapneumovirus in upper respiratory tract infections in children: a 20-year experience.

Authors:  John V Williams; Chiaoyin K Wang; Chin-Fen Yang; Sharon J Tollefson; Frances S House; Josh M Heck; Marla Chu; Jennifer B Brown; Linda D Lintao; Joe D Quinto; David Chu; Richard R Spaete; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  J Infect Dis       Date:  2005-12-30       Impact factor: 5.226

4.  Epidemiology of respiratory syncytial virus in various regions within North Carolina during multiple seasons.

Authors:  David A Wilfret; Brent T Baker; Elizabeth Palavecino; Cassandra Moran; Daniel K Benjamin
Journal:  N C Med J       Date:  2008 Nov-Dec

5.  The relationship of meteorological conditions to the epidemic activity of respiratory syncytial virus.

Authors:  S Yusuf; G Piedimonte; A Auais; G Demmler; S Krishnan; P Van Caeseele; R Singleton; S Broor; S Parveen; L Avendano; J Parra; S Chavez-Bueno; T Murguía De Sierra; E A F Simoes; S Shaha; R Welliver
Journal:  Epidemiol Infect       Date:  2007-03-08       Impact factor: 2.451

6.  Understanding the transmission dynamics of respiratory syncytial virus using multiple time series and nested models.

Authors:  L J White; J N Mandl; M G M Gomes; A T Bodley-Tickell; P A Cane; P Perez-Brena; J C Aguilar; M M Siqueira; S A Portes; S M Straliotto; M Waris; D J Nokes; G F Medley
Journal:  Math Biosci       Date:  2006-09-05       Impact factor: 2.144

7.  Meteorological factors and respiratory syncytial virus seasonality in subtropical Australia.

Authors:  C Morley; K Grimwood; S Maloney; R S Ware
Journal:  Epidemiol Infect       Date:  2018-03-21       Impact factor: 4.434

8.  Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children.

Authors:  Saleh Al-Alaiyan; Paul Pollack; Gerard F Notario
Journal:  Drugs Context       Date:  2015-02-27

9.  Ten years' experience with year-round active surveillance of up to 19 respiratory pathogens in children.

Authors:  Josef A I Weigl; Wolfram Puppe; Claudius U Meyer; Reinhard Berner; Johannes Forster; Heinz J Schmitt; Fred Zepp
Journal:  Eur J Pediatr       Date:  2007-06-14       Impact factor: 3.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.